Peng Liang
Vorsitzender bei CLOVER BIOPHARMACEUTICALS, LTD.
Vermögen: 9 Mio $ am 30.04.2024
Aktive Positionen von Peng Liang
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CLOVER BIOPHARMACEUTICALS, LTD. | Vorsitzender | 31.10.2018 | - |
Clover Biopharmaceuticals Aus Pty Ltd. | Direktor/Vorstandsmitglied | 01.06.2017 | - |
Clover Biopharmaceuticals USA, Inc. | Präsident | 01.04.2020 | - |
Treasurer | 01.04.2020 | - | |
Zhejiang Clover Biopharmaceutical, Inc. | Vorsitzender | 01.08.2016 | - |
Clover Biopharmaceuticals Hong Kong Ltd. | Direktor/Vorstandsmitglied | 01.11.2018 | - |
Karriereverlauf von Peng Liang
Ehemalige bekannte Positionen von Peng Liang
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Vanderbilt University | Corporate Officer/Principal | 01.07.2008 | 01.06.2009 |
Sichuan Clover Biopharmaceuticals, Inc
Sichuan Clover Biopharmaceuticals, Inc Pharmaceuticals: MajorHealth Technology Sichuan Clover Biopharmaceuticals, Inc is a clinical-stage biotechnology company based in Chengdu, China. Clover Biopharmaceuticals' mission is to leverage their trimer-tag technology and in-house manufacturing capabilities to develop and deliver innovative and affordable medical solutions. The Chinese company is committed to partnering with leading healthcare organizations to advance their breakthrough pipeline programs and deliver them to patients. The company's pipeline includes many vaccine and therapeutic candidates for the treatment of infectious disease, cancer, and autoimmune disease, created using trimer-tag platform technology. The company was founded in 2007 by Peng Liang, and Joshua Liang has been the CEO of the company since 2016. | Gründer | 01.06.2007 | - |
GenHunter Corp. | Gründer | 01.10.1992 | - |
Präsident | 01.10.1992 | - |
Ausbildung von Peng Liang
Peking University | Undergraduate Degree |
University of Illinois | Doctorate Degree |
Statistik
International
China | 6 |
Vereinigte Staaten | 4 |
Australien | 2 |
Operativ
Chairman | 2 |
Founder | 2 |
President | 2 |
Sektoral
Consumer Services | 4 |
Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
CLOVER BIOPHARMACEUTICALS, LTD. | Health Technology |
Private Unternehmen | 6 |
---|---|
Sichuan Clover Biopharmaceuticals, Inc
Sichuan Clover Biopharmaceuticals, Inc Pharmaceuticals: MajorHealth Technology Sichuan Clover Biopharmaceuticals, Inc is a clinical-stage biotechnology company based in Chengdu, China. Clover Biopharmaceuticals' mission is to leverage their trimer-tag technology and in-house manufacturing capabilities to develop and deliver innovative and affordable medical solutions. The Chinese company is committed to partnering with leading healthcare organizations to advance their breakthrough pipeline programs and deliver them to patients. The company's pipeline includes many vaccine and therapeutic candidates for the treatment of infectious disease, cancer, and autoimmune disease, created using trimer-tag platform technology. The company was founded in 2007 by Peng Liang, and Joshua Liang has been the CEO of the company since 2016. | Health Technology |
GenHunter Corp. | |
Clover Biopharmaceuticals USA, Inc. | |
Zhejiang Clover Biopharmaceutical, Inc. | |
Clover Biopharmaceuticals Aus Pty Ltd. | |
Clover Biopharmaceuticals Hong Kong Ltd. |
- Börse
- Insiders
- Peng Liang
- Erfahrung